These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21371763)

  • 21. Heart fatty acid binding protein (H-FABP) as a diagnostic biomarker in patients with acute coronary syndrome.
    Gururajan P; Gurumurthy P; Nayar P; Srinivasa Nageswara Rao G; Babu S; Cherian KM
    Heart Lung Circ; 2010 Nov; 19(11):660-4. PubMed ID: 20674495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate-specific antigen and acute myocardial infarction: a possible new intriguing scenario.
    Patanè S; Marte F
    Int J Cardiol; 2009 May; 134(3):e147-9. PubMed ID: 19157588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The specific features of coronary artery lesion in patients with signs of high cardiac risk in non-ST segment elevation acute coronary syndrome].
    Iarosh VB; Eroshkin IA; Iakovlev VB
    Vestn Rentgenol Radiol; 2011; (2):12-7. PubMed ID: 21866819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ischemia-modified albumin in differential diagnosis of acute coronary syndrome without ST elevation and unstable angina pectoris.
    Wudkowska A; Goch J; Goch A
    Kardiol Pol; 2010 Apr; 68(4):431-7. PubMed ID: 20425705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Zealand 2012 guidelines for the management of non ST-elevation acute coronary syndromes.
    Non ST-Elevation Acute Coronary Syndrome Guidelines Group and the New Zealand Branch of the Cardiac Society of Australia and New Zealand
    N Z Med J; 2012 Jun; 125(1357):122-47. PubMed ID: 22854366
    [No Abstract]   [Full Text] [Related]  

  • 26. Quantitative troponin and death, cardiogenic shock, cardiac arrest and new heart failure in patients with non-ST-segment elevation acute coronary syndromes (NSTE ACS): insights from the Global Registry of Acute Coronary Events.
    Jolly SS; Shenkman H; Brieger D; Fox KA; Yan AT; Eagle KA; Steg PG; Lim KD; Quill A; Goodman SG;
    Heart; 2011 Feb; 97(3):197-202. PubMed ID: 21076124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HDL-cholesterol level provides additional prognosis in acute coronary syndromes.
    Correia LC; Rocha MS; Esteves JP
    Int J Cardiol; 2009 Aug; 136(3):307-14. PubMed ID: 18706714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of copeptin and high-sensitivity cardiac troponin T assay in unstable angina and non-ST-segment elevation myocardial infarction: a pilot study.
    Meune C; Zuily S; Wahbi K; Claessens YE; Weber S; Chenevier-Gobeaux C
    Arch Cardiovasc Dis; 2011 Jan; 104(1):4-10. PubMed ID: 21276572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative blood reverse transcriptase-PCR assays for prostate-specific antigen and human glandular kallikrein for prediction of prostate cancer progression after radical prostatectomy.
    Shariat SF; Gottenger E; Nguyen C; Song W; Kattan MW; Andenoro J; Wheeler TM; Spencer DM; Slawin KM
    Cancer Res; 2002 Oct; 62(20):5974-9. PubMed ID: 12384565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
    Scorilas A; Plebani M; Mazza S; Basso D; Soosaipillai AR; Katsaros N; Pagano F; Diamandis EP
    Prostate; 2003 Feb; 54(3):220-9. PubMed ID: 12518327
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome.
    Novo G; Assennato P; Caruso M; Turturici C; Balistreri CR; Amoroso GR; Fazio G; Rotolo A; Coppola G; Hoffmann E; Caruso C; Novo S
    Minerva Cardioangiol; 2009 Feb; 57(1):7-11. PubMed ID: 19202515
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer.
    Stephan C; Jung K; Nakamura T; Yousef GM; Kristiansen G; Diamandis EP
    Int J Urol; 2006 Mar; 13(3):238-43. PubMed ID: 16643616
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of guidelines-recommended management and outcomes among women and men with low-level troponin elevation: insights from CRUSADE.
    Halim SA; Mulgund J; Chen AY; Roe MT; Peterson ED; Gibler WB; Ohman EM; Newby LK
    Circ Cardiovasc Qual Outcomes; 2009 May; 2(3):199-206. PubMed ID: 20031838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum ferritin and acute coronary syndrome: a strong prognostic factor?
    Dominguez-Rodriguez A; Carrillo-Perez Tome M; Hernandez-Garcia C; Arroyo-Ucar E; Juarez-Prera R; Blanco-Palacios G; Abreu-Gonzalez P
    Int J Cardiol; 2011 Oct; 152(1):129-30. PubMed ID: 21856027
    [No Abstract]   [Full Text] [Related]  

  • 35. [Acute coronary syndrome: guidelines and geriatrics specificity].
    Falconnet C; Carballo S; Roffi M; Keller PF; Perrenoud JJ
    Rev Med Suisse; 2009 May; 5(204):1137-8, 1140-2, 1144-7. PubMed ID: 19580211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.
    Haese A; Vaisanen V; Lilja H; Kattan MW; Rittenhouse HG; Pettersson K; Chan DW; Huland H; Sokoll LJ; Partin AW
    J Urol; 2005 Mar; 173(3):752-6. PubMed ID: 15711262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of low high-density lipoprotein cholesterol (HDL-C) as a marker of residual cardiovascular risk among acute coronary syndrome patients from Oman.
    Al-Zakwani I; Sulaiman K; Al-Rasadi K; Mikhailidis DP
    Curr Med Res Opin; 2011 Apr; 27(4):879-85. PubMed ID: 21332274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical scores and patient risk stratification in non-ST elevation acute coronary syndrome.
    Fernández-Bergés D; Bertomeu-Gonzalez V; Sánchez PL; Cruz-Fernandez JM; Arroyo R; Barriales Álvarez V; Carrasco Sánchez FJ; Dalli E; Castro Beiras A; Kaski JC;
    Int J Cardiol; 2011 Jan; 146(2):219-24. PubMed ID: 20439123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.
    Viswanathan K; Kilcullen N; Morrell C; Thistlethwaite SJ; Sivananthan MU; Hassan TB; Barth JH; Hall AS
    J Am Coll Cardiol; 2010 Jun; 55(23):2590-8. PubMed ID: 20513600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
    Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
    J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.